Publicaciones (60) Publicaciones de ANGEL PLACIDO LLANEZA COTO

2024

  1. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis

    Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

2023

  1. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  2. Population-based survey on menopausal symptoms and treatment use

    Climacteric, Vol. 26, Núm. 1, pp. 47-54

2022

  1. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group

    Maturitas, Vol. 166, pp. 65-85

  2. Resilience, Perceived Stress, and Depressed Mood in Women Under in Vitro Fertilization Treatment

    Reproductive Sciences, Vol. 29, Núm. 3, pp. 816-822

2021

  1. Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement

    Maturitas, Vol. 144, pp. 4-10

  2. Nulla dies sine linea (2014-2018)

    Historia de la AEEM: 30 aniversario : 1991-2021 (Editorial Universidad de Granada), pp. 151-164

  3. Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire

    Menopause (New York, N.Y.), Vol. 28, Núm. 8, pp. 935-942

  4. Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study

    BMC Women's Health, Vol. 21, Núm. 1

2020

  1. Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report

    Case Reports in Women's Health, Vol. 27

  2. Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study

    BMC Women's Health, Vol. 20, Núm. 1

  3. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

    Maturitas, Vol. 137, pp. 57-62

  4. Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”

    Maturitas

  5. The thromboembolic risk in covid-19 women under hormonal treatment group

    Maturitas

2019

  1. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial

    Gynecological Endocrinology, Vol. 35, Núm. 8, pp. 695-700

  2. Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study

    Sexual Medicine, Vol. 7, Núm. 2, pp. 207-216

2018

  1. "Hablemos de otra forma" acerca de la terapia hormonal en la menopausia

    Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 221-226

  2. Aeem-sego position statement on menopausal hormone therapy

    Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 230-234

  3. What do TSECs provide in the menopausal hormone therapy?

    Gynecological Endocrinology, Vol. 34, Núm. 10, pp. 826-832

2017

  1. Clinical symptoms and quality of life: Hot flashes and mood

    Menopause: A Comprehensive Approach (Springer International Publishing), pp. 69-78